Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today…
Oxford Biomedica announces CFO transition Oxford Biomedica announces Chief Financial Officer transition…
Oxford Biomedica completes acquisition of ABL Europe Oxford Biomedica completes acquisition of ABL Europe …
Global Gene Therapy Market Size to Worth USD 49.21 Billion by 2032 | CAGR of 20.46% The Global Gene Therapy Market Size was valued at USD 7.65 Billion in 2022 and the Worldwide Gene Therapy Market…
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023 The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market…
Oxford BioMedica expands licence deal with Cabaletta Bio Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
IN BRIEF: Oxford BioMedica launches lentiviral vector system Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Oxford Biomedica plc reports FY results Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Oxford BioMedica swings to full-year loss amid lower volumes Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Oxford Biomedica Posts FY Loss LONDON (dpa-AFX) - Oxford Biomedica Plc. (OXB.L) reported that its loss attributable to owners of the company for the year…
Oxford BioMedica 2022 Results Delayed Due to Auditor Time Extension Oxford BioMedica 2022 Results Delayed Due to Auditor Time Extension...…
Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023 Dr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023...…
IN BRIEF: Oxford BioMedica confirms start date of Mathias as new CEO Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…